Head and Neck Cancer Disease Model Development

Head & Neck Cancer Preclinical Solutions

Online Inquiry

Name *

Email *

Phone *

Services Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Our expertise is essential in improving the understanding of head and neck cancer as we develop sophisticated models for disease research. At Alfa Cytology, we utilize cutting-edge technology and a dedicated team to create innovative models that accurately reflect tumor biology. Our specialists, skilled in oncology and preclinical research, are committed to delivering reliable model development services tailored to your specific research needs.

Overview of Disease Models for Head and Neck Cancer

Disease models for Head and Neck Cancer (HNC) are critical tools for understanding tumor biology, progression, and treatment responses. These models range from in vitro systems, such as 2D and 3D cell cultures, to in vivo models like xenografts and genetically engineered mice. In vitro models allow for the examination of cellular mechanisms and drug interactions, while in vivo models provide insights into tumor-host interactions and the complexity of tumor microenvironments. By integrating various modeling approaches, researchers can more accurately simulate HNC, facilitating drug discovery and the development of personalized therapies. The ongoing advancement of these models is vital for uncovering new therapeutic targets and improving patient outcomes in Head and Neck Cancer.

Model Type	Key Construction	Advantages	Applications
2D	Monolayer cell culture	High-throughput, low cost	Drug screening, mechanistic studies
3D Organoid	Patient-derived tissue culture	Retains heterogeneity, personalized	Precision medicine, drug resistance
PDX	Patient tumor transplanted in mice	High clinical relevance	Preclinical drug efficacy testing
GEMMs	Genetically engineered mutations	Mimics spontaneous tumor progression	Tumor microenvironment, immunology

Our Services

At Alfa Cytology, we offer specialized development services for head and neck cancer disease modeling, focused on enhancing the preclinical research and development efforts of our partners. Our comprehensive services include:

Patient-Derived Xenograft (PDX) Models

Rapid PDX model generation from patient biopsies/surgical samples (primary/metastatic), preserving tumor heterogeneity and TME.
Low-passage (P1-P3) models with genomic stability for reliable chemo/targeted/IO therapy testing.

Genetically Engineered Mouse Models

Custom HPV+/- HNC models (e.g., K14-Cre;Trp53fl/fl or HPV E6/E7 transgenic).
Driver mutation models (PIK3CA, CDKN2A KO) to study resistance pathways.
Orthotopic models (tongue/oral mucosa) for invasive and metastatic studies.

3D Organoid Models

HNC organoids are derived from patient/PDX tumors and retain original biomarkers.
High-throughput drug sensitivity testing (mono/combination therapies).
TME co-culture systems (fibroblasts/immune cells) for realistic microenvironments.

Syngeneic Mouse Models

MOC1/MOC2/SCCVII models with baseline TME profiling
Anti-PD-1/CTLA-4 response benchmarking
Custom radiation combination protocols

Overall, the development of disease models for head and neck cancer highlights the potential of innovative research tools to enhance preclinical studies and improve therapeutic outcomes. At Alfa Cytology, we are committed to advancing the field of disease modeling through state-of-the-art research and development. Contact us today to discover how our disease model development services can contribute to the success of your projects.

For research use only.